← Evidence map

ArticleActa psychiatrica Scandinavica2026

Correction to "A Double-Blind, Placebo-Controlled Trial of Rosiglitazone for Clozapine-Induced Glucose Metabolism Impairment in Patients with Schizophrenia".

PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41184203